Caroline Rasmussen, DVM, PhD, is Senior Director, Nonclinical Development at Hemab. She brings over a decade of experience within the area of nonclinical development – ranging from early drug development to marketing authorization. She started her career at Novo Nordisk A/S working mainly within the hemostasis portfolio. Most recently, Caroline was employed at Ascendis Pharma A/S as Director of Toxicology and Safety Pharmacology, from where she brings a strong focus on unmet medical needs, science, and animal welfare. She earned her DVM and PhD at the Faculty of Life Sciences, Copenhagen University. As her doctorial research focused on the cardiovascular field, she has numerous publications within this area.